» Authors » K L Cooper

K L Cooper

Explore the profile of K L Cooper including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 51
Citations 662
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Volk L, Cooper K, Jiang T, Paffett M, Hudson L
Toxicol Appl Pharmacol . 2022 Sep; 454:116230. PMID: 36087615
Arsenite interferes with DNA repair protein function resulting in the retention of UV-induced DNA damage. Accumulated DNA damage promotes replication stress which is bypassed by DNA damage tolerance pathways such...
2.
Bruehl F, Cooper K, Kilpatrick S, Weindel M, Ganea M, Astbury C, et al.
Case Rep Pathol . 2019 Jun; 2019:9012878. PMID: 31236300
Angiomatoid fibrous histiocytoma (AFH) is a rare soft tissue tumor that is most commonly reported to arise in the subcutaneous tissues of the upper extremities in adolescents and young adults....
3.
Reeder A, Attar M, Nazario L, Bathula C, Zhang A, Hochbaum D, et al.
Br J Cancer . 2015 Apr; 112(9):1461-70. PMID: 25880007
Background: The mechanisms by which stress hormones impact triple-negative breast cancer (TNBC) etiology and treatment are unclear. We have previously shown that stress hormones, cortisol, and catecholamines induce rapid DNA...
4.
Bowman W, Cooper K, Unni K, Sim F
Orthopedics . 2014 May; 6(2):196-204. PMID: 24823237
No abstract available.
5.
Pritchard D, Cooper K, Unni K
Orthopedics . 2014 May; 5(5):587-98. PMID: 24822858
No abstract available.
6.
Bowman W, Cooper K, Unni K, Sim F
Orthopedics . 2014 May; 5(1):77-85. PMID: 24822717
No abstract available.
7.
Eckardt J, Cooper K, Unni K, Sim F
Orthopedics . 2014 May; 3(11):1142-52. PMID: 24822709
No abstract available.
8.
Sim F, Cooper K, Dahlin D
Orthopedics . 2014 May; 4(7):798-814. PMID: 24822631
No abstract available.
9.
van Londen G, Beckjord E, Dew M, Cooper K, Davidson N, Bovbjerg D, et al.
Support Care Cancer . 2013 Nov; 22(4):937-45. PMID: 24271937
Background: Breast cancer survivors often receive long-term adjuvant endocrine therapy (AET) to reduce recurrence risk. Adherence to AET is suboptimal, which may be due to the experience of symptoms and/or...
10.
Cooper K, Yager J, Hudson L
Toxicol Lett . 2013 Nov; 224(3):407-15. PMID: 24270004
The rise of melanoma incidence in the United States is a growing public health concern. A limited number of epidemiology studies suggest an association between arsenic levels and melanoma risk....